Who are the key players in the Omisirge Market Report 2026 market?

Major companies operating in the Omisirge Market Report 2026 market are Major companies operating in the omisirge market are Gamida Cell Ltd. Read More

What are the major opportunities in the Omisirge market? What are the strategies for the Omisirge market?

For detailed insights on the major opportunities and strategies in the Omisirge market, Read More

How does the Omisirge market relate to the overall economy and other similar markets?

For detailed insights on Omisirge's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Omisirge market growth? SWOT analysis of the Omisirge market.

For detailed insights on the key dynamics influencing the Omisirge market growth and SWOT analysis of the Omisirge industry, Read More

Omisirge Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Omisirge Market Report 2026

Name: Omisirge Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Clinical Indication (Leukemia, Lymphoma, Myeloma, Other Hematologic Malignancies), By Distribution Channel (Direct Sales, Distributors), By End User (Hospitals And Clinics, Ambulatory Surgical Centers) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Omisirge Market Overview

• The Omisirge market growth in the historic period has been driven by increasing incidence of hematologic malignancies, limitations of conventional cord blood transplantation

• Market expansion is supported by expansion of personalized cell therapy pipelines, rising investments in regenerative medicine

• Growth Driver: Rising Demand For Personalized Treatments Driving Growth In The Market

• Market Trend: Technological Advancements Enhancing Transplant Efficiency And Patient Outcomes

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Omisirge Market?

Omisirge is an advanced cell therapy used in allogeneic hematopoietic stem cell transplantation (HSCT) for patients with blood cancers or disorders. It is derived from umbilical cord blood and designed to expedite neutrophil recovery, reducing the risk of infection and complications after transplantation. Omisirge contains expanded hematopoietic progenitor cells (CD34+ cells) cultured to enhance their number and functionality, enabling faster engraftment compared to standard cord blood transplantation.

The main types of indications for omisirge include leukemia, lymphoma, myeloma, and others. Leukemia is a type of cancer that affects the blood and bone marrow, leading to the production of abnormal white blood cells. It is distributed through both direct sales and distributors and is used by hospitals and clinics, and ambulatory surgical centers.

Omisirge Market Global Report 2026 Market Report bar graph

What Is The Omisirge Market Size and Share 2026?

The growth in the historic period can be attributed to increasing incidence of hematologic malignancies, limitations of conventional cord blood transplantation, early clinical success of cell expansion technologies, growing use of allogeneic stem cell transplants, regulatory approvals for advanced cell therapies.

What Is The Omisirge Market Growth Forecast?

The growth in the forecast period can be attributed to expansion of personalized cell therapy pipelines, rising investments in regenerative medicine, increasing adoption of advanced transplantation protocols, growing focus on reducing post-transplant complications, expansion of cell therapy manufacturing infrastructure. Major trends in the forecast period include increasing adoption of expanded cord blood therapies, rising use of ex vivo cell expansion techniques, growing focus on faster neutrophil engraftment, expansion of allogeneic hsct applications, enhanced manufacturing scalability for cell therapies.

Book your 30 minutes free consultation with our research experts

Global Omisirge Market Segmentation

1) By Clinical Indication: Leukemia, Lymphoma, Myeloma, Other Hematologic Malignancies

2) By Distribution Channel: Direct Sales, Distributors

3) By End User: Hospitals And Clinics, Ambulatory Surgical Centers

What Is The Driver Of The Omisirge Market?

The increasing demand for personalized treatments is expected to propel the growth of the omisirge market going forward. Personalized treatments are medical interventions tailored to an individual's specific genetic, environmental, and lifestyle factors to optimize effectiveness and minimize side effects. The demand for personalized treatments is rising due to advancements in genetic research, increased awareness of individualized healthcare, and the growing recognition that tailored therapies offer improved efficacy and fewer side effects compared to traditional one-size-fits-all approaches. Omisirge enhances personalized treatments by leveraging its ability to adapt to individual patient needs, targeting specific immune responses, and optimizing therapeutic outcomes based on the unique characteristics of each patient's cancer profile.For instance, in February 2024, Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, a significant increase from the six approved in 2022. Therefore, the increasing demand for personalized treatments is expected to drive the growth of the omisirge industry.

Key Players In The Global Omisirge Market

Major companies operating in the omisirge market are Gamida Cell Ltd.

Global Omisirge Market Trends and Insights

Major companies operating in the Omisirge market are focusing on developing technological advancements, such as omidubicel-onlv, to enhance transplant efficiency and improve patient recovery outcomes. Omidubicel-onlv is an allogeneic, stem-cell–based therapy derived from umbilical cord blood and engineered to enhance cell expansion for faster engraftment. For instance, in May 2023, the U.S. Food and Drug Administration, a US-based federal agency, approved Gamida Cell’s product Omisirge, which aims to improve stem cell engraftment and reduce infection risks in transplant patients. The FDA approval of Omisirge introduced an enhanced, expanded cord-blood–derived cell therapy designed to accelerate neutrophil recovery and lower infection risk in patients with hematologic malignancies. It offers a more reliable engraftment profile compared to traditional cord blood, making transplants faster and clinically safer.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Omisirge Market?

In March 2025, Ayrmid Pharma Ltd., a U.S.-based cell therapy company specializing in nicotinamide-enhanced allogeneic progenitor cell therapies, partnered with RoslinCT to advance manufacturing capabilities and support the scalable production of its cell therapy programs. With this partnership, Ayrmid secures a dual sourcing strategy to ensure a stable, commercial-scale supply of Omisirge (omidubicel-only) by transferring the technology and enabling RoslinCT’s Hopkinton, Massachusetts, facility to manufacture the product, thereby enhancing its manufacturing capacity and supply reliability. RoslinCT is a Scotland-based contract development and manufacturing organization (CDMO) providing process development, analytical services, and GMP manufacturing for advanced cell and gene therapies.

Regional Insights

North America was the largest region in the omisirge market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Omisirge Market?

The omisirge market consists of sales of cell therapy products, gene therapy products, cord blood-derived products, and tissue engineering products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Omisirge Market Report 2026?

The omisirge market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the omisirge industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Omisirge Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$ billion
Revenue Forecast In 2035	$ billion
Growth Rate	No CAGR found from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Clinical Indication, Distribution Channel, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Gamida Cell Ltd.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Omisirge Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Omisirge Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Omisirge Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Omisirge Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Industry 4.0 & Intelligent Manufacturing

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Increasing Adoption Of Expanded Cord Blood Therapies

4.2.2 Rising Use Of Ex Vivo Cell Expansion Techniques

4.2.3 Growing Focus On Faster Neutrophil Engraftment

4.2.4 Expansion Of Allogeneic Hsct Applications

4.2.5 Enhanced Manufacturing Scalability For Cell Therapies

5. Omisirge Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Transplant Centers

5.3 Oncology Clinics

5.4 Research Hospitals

5.5 Academic Medical Centers

6. Omisirge Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Omisirge Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Omisirge PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Omisirge Market Size, Comparisons And Growth Rate Analysis

7.3. Global Omisirge Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Omisirge Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Omisirge Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Omisirge Market Segmentation

9.1. Global Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Leukemia, Lymphoma, Myeloma, Other Hematologic Malignancies

9.2. Global Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Direct Sales, Distributors

9.3. Global Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Ambulatory Surgical Centers

10. Omisirge Market Regional And Country Analysis

10.1. Global Omisirge Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Omisirge Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Omisirge Market

11.1. Asia-Pacific Omisirge Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Omisirge Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Omisirge Market

12.1. China Omisirge Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Omisirge Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Omisirge Market

13.1. India Omisirge Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Omisirge Market

14.1. Japan Omisirge Market Overview

14.2. Japan Omisirge Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Omisirge Market

15.1. Australia Omisirge Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Omisirge Market

16.1. South Korea Omisirge Market Overview

16.2. South Korea Omisirge Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Omisirge Market

17.1. Western Europe Omisirge Market Overview

17.2. Western Europe Omisirge Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Omisirge Market

18.1. UK Omisirge Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Omisirge Market

19.1. Germany Omisirge Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Omisirge Market

20.1. France Omisirge Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Omisirge Market

21.1. Eastern Europe Omisirge Market Overview

21.2. Eastern Europe Omisirge Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Omisirge Market

22.1. North America Omisirge Market Overview

22.2. North America Omisirge Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Omisirge Market

23.1. USA Omisirge Market Overview

23.2. USA Omisirge Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Omisirge Market

24.1. Canada Omisirge Market Overview

24.2. Canada Omisirge Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Omisirge Market

25.1. South America Omisirge Market Overview

25.2. South America Omisirge Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Omisirge Market

26.1. Middle East Omisirge Market Overview

26.2. Middle East Omisirge Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Omisirge Market

27.1. Africa Omisirge Market Overview

27.2. Africa Omisirge Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Omisirge Market Regulatory and Investment Landscape

29. Omisirge Market Competitive Landscape And Company Profiles

29.1. Omisirge Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Omisirge Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Omisirge Market Company Profiles

29.3.1. Gamida Cell Ltd. Overview, Products and Services, Strategy and Financial Analysis

30. Global Omisirge Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Omisirge Market

32. Omisirge Market High Potential Countries, Segments and Strategies

32.1 Omisirge Market In 2030 - Countries Offering Most New Opportunities

32.2 Omisirge Market In 2030 - Segments Offering Most New Opportunities

32.3 Omisirge Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Omisirge Market, Overview Of Key Products - Product Examples

Table 2: Global Omisirge Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Omisirge Market, Supply Chain Analysis

Table 4: Global Omisirge Market, Major Raw Material Providers

Table 5: Global Omisirge Market, Major Resource Providers

Table 6: Global Omisirge Market, Major Manufacturers (Suppliers)

Table 7: Global Omisirge Market, Major Distributors And Channel Partners

Table 8: Global Omisirge Market, Key Technologies & Future Trends

Table 9: Global Omisirge Market, Major Trends

Table 10: Global Omisirge Market, Major End Users

Table 11: Global Omisirge Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Omisirge Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Omisirge Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Omisirge Market - TAM, US$ Billion, 2025

Table 15: Global Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Omisirge Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Omisirge Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Asia-Pacific, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Asia-Pacific, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Asia-Pacific, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: China, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: China, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: China, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: India, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: India, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: India, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Japan, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: Japan, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Japan, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Australia, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Australia, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Australia, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: South Korea, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: South Korea, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: South Korea, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Western Europe, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Western Europe, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Western Europe, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: UK, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: UK, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: UK, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Germany, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Germany, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Germany, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: France, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: France, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: France, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Eastern Europe, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Eastern Europe, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Eastern Europe, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: North America, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: North America, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: North America, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: USA, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: USA, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: USA, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Canada, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Canada, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Canada, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: South America, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: South America, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: South America, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Middle East, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Middle East, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Middle East, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Africa, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Africa, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Africa, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Global Omisirge Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 72: Global Omisirge Market - Company Scoring Matrix

Table 73: Gamida Cell Ltd. Financial Performance

Table 74: Global Omisirge Market, Competitive Benchmarking (In USD Billions)

Table 75: Global Omisirge Market, Competitive Dashboard

Table 76: Global Omisirge Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 77: Global, Omisirge Market Size Gain ($ Billion), Segmentation By Clinical Indication, 2025 – 2030

Table 78: Global, Omisirge Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Table 79: Global, Omisirge Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

Figure 1: Global Omisirge Market, Overview Of Key Products - Product Examples

Figure 2: Global Omisirge Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Omisirge Market, Supply Chain Analysis

Figure 4: Global Omisirge Market, Major Raw Material Providers

Figure 5: Global Omisirge Market, Major Resource Providers

Figure 6: Global Omisirge Market, Major Manufacturers (Suppliers)

Figure 7: Global Omisirge Market, Major Distributors And Channel Partners

Figure 8: Global Omisirge Market, Key Technologies & Future Trends

Figure 9: Global Omisirge Market, Major Trends

Figure 10: Global Omisirge Market, Major End Users

Figure 11: Global Omisirge Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Omisirge Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Omisirge Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Omisirge Market - TAM, US$ Billion, 2025

Figure 15: Global Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Omisirge Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Omisirge Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Asia-Pacific, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Asia-Pacific, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Asia-Pacific, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: China, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: China, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: China, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: India, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: India, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: India, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Japan, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: Japan, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Japan, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Australia, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Australia, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Australia, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: South Korea, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: South Korea, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: South Korea, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Western Europe, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Western Europe, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Western Europe, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: UK, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: UK, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: UK, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Germany, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Germany, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Germany, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: France, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: France, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: France, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Eastern Europe, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Eastern Europe, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Eastern Europe, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: North America, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: North America, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: North America, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: USA, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: USA, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: USA, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Canada, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Canada, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Canada, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: South America, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: South America, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: South America, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Middle East, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Middle East, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Middle East, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Africa, Omisirge Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Africa, Omisirge Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Africa, Omisirge Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Global Omisirge Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 72: Global Omisirge Market - Company Scoring Matrix

Figure 73: Gamida Cell Ltd. Financial Performance

Figure 74: Global Omisirge Market, Competitive Benchmarking (In USD Billions)

Figure 75: Global Omisirge Market, Competitive Dashboard

Figure 76: Global Omisirge Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 77: Global, Omisirge Market Size Gain ($ Billion), Segmentation By Clinical Indication, 2025 – 2030

Figure 78: Global, Omisirge Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Figure 79: Global, Omisirge Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Aesthetic Medicine Market Revenue Outlook: Strategic Insights and Forecast to 2029

Industry Forecast: Alpha Mannosidosis Market to Generate $33.81 Billion Revenue by 2029

CAGR of 3.1% Projected for Analgesics Market From 2025 to 2029

Emerging Trends and Growth Drivers in the Anesthetics Market Through 2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the MSI-H and DMMR Market with 2025 insights from The Business Research Company.

Autologous Cell Therapy Market Report 2026 - Global Outlook – By Therapy (Autologous Stem Cell Therapy, Autologous Cellular Immunotherapies), By Source (Bone Marrow, Epidermis, Mesenchymal Stem Cells, Hematopoietic Stem ...

Stem Cell Therapy Market Report 2026 - Global Outlook – By Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), By Cell Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells), By Ap...

Cell Therapy Technologies Market Report 2026 - Global Outlook – By Product (Consumables, Equipment, Systems And Software), By Cell Type (T-Cells, Stem Cells, Other Cell Types), By Process (Cell Processing, Cell Preservat...

Cell Therapy Market Report 2026 - Global Outlook – By Technique (Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy ), By Therapy Type (Allogeneic Therapies, ...

Cell Therapy Human Raw Materials Market Report 2026 - Global Outlook – By Product (Cell Culture Media, Cell Culture Sera, Cell Culture Supplements, Reagents And Buffers, Other Raw Materials), By Type Of Cell Therapy (Den...

Allogeneic Cell Therapy Market Report 2026 - Global Outlook – By Type (Stem Cell Therapies, Non-Stem Cell Therapies ), By Therapeutic Area (Hematological Disorders, Dermatological Disorders), By End User (Hospitals, Spec...

Personalized Cell Therapy Market Report 2026 - Global Outlook – By Cell Type (Lymphocytes, Mesenchymal Stem Cells (MSCs), Hematopoietic Stem Cells, Other Cell Types), By Technique (Cell Engineering And Expansion Techniqu...

Frequently Asked Questions

How big is the Omisirge Market?

The Omisirge market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

What is the Omisirge market growth?

The global Omisirge market is expected to grow at a CAGR of nan% from 2026 to 2035 to reach $ billion by 2035.

Who are the key players in Omisirge market?

Some Key Players in the Omisirge market Include, Gamida Cell Ltd. .

What is the anticipated growth trend for the Omisirge market?

Major trend in this market includes: Technological Advancements Enhancing Transplant Efficiency And Patient Outcomes. For further insights on this market. request a sample here

Which region has the most growth potential in the Omisirge market?

North America was the largest region in the omisirge market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the omisirge market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.